Genitourinary Steering Committee

The Genitourinary Steering Committee (GUSC) was established in 2008.  The GUSC is currently composed of the Steering Committee and a task force.  Members of the GUSC include representatives from the Cooperative Groups with active genitourinary programs, representatives from the prostate, renal, and bladder Specialized Programs of Research Excellence (SPORE) and other translational scientists, community oncologists, biostatisticians, pathologists, patient advocates, and NCI staff.

Mission Statement

The GUSC functions to harmonize an efficient, cost-effective, science-driven, and transparent process that will identify and promote the "Best Science" in genitourinary cancer clinical research by addressing the design and prioritization of phase III trials and large phase II studies.

Roster of Genitourinary Steering Committee members
Eric Klein, M.D., George Wilding, M.D. and Anthony Zietman, M.D., Co-chairs

Task Forces

• Prostate Cancer: Michael Carducci, M.D., Deborah A. Kuban, M.D., Andrew Stephenson, M.D. Co-chairs

CCCT Contact: Steven Krosnick, M.D.